Technology

Hulu's Get Huge Follows a Steroid Influencer and the Online Operation Behind Him

Martin HollowayPublished 12m ago5 min readBased on 1 source
Reading level
Hulu's Get Huge Follows a Steroid Influencer and the Online Operation Behind Him
Photo by Pavel Danilyuk on Pexels

Hulu's three-part docuseries Get Huge: Looksmaxxing to Death, directed by Stacey Lee, centers on Anthony “Tony Huge” Hughes, a steroid-focused influencer and chemical biohacking creator. The series, reported on November 16, 2026, follows Hughes' online operation rather than a single event, and it is built around the man who runs it.

Hughes' path to influencer status is unusual. According to The Verge, he previously worked as a bankruptcy lawyer and as a supplement salesman, and he was investigated by the FDA for selling unapproved performance-enhancing drugs. The chemical biohacking content he now produces, which is self-experimentation with drugs and compounds, sits on that commercial lineage. It targets the same product categories and the same audience of men pursuing physical and cosmetic optimization.

Much of the series takes place in Pattaya, Thailand. There, Hughes produces content showing partying and injections of muscle-swelling substances. The setting shapes the format. A city known for nightlife and cross-border medical tourism gives the camera a backdrop of excess, and it places the subject outside the regulatory reach that governs his product sales in the United States.

Hughes is not depicted alone. The series features biohacking and manosphere influencers Leo Longevity, Elon Muscular and Connor Murphy as members of his entourage in Thailand. Leo Longevity's legal name is Laith Abdallah Algaz. The group forms a small creator ecosystem, in which each member's content amplifies the others'. The shared vocabulary of longevity, hormones and “looksmaxxing” (the online pursuit of cosmetic self-optimization) becomes a commercial identity.

Distribution is another thread. Hughes' videos now appear primarily on Rumble and X, following multiple account bans on YouTube and TikTok. That migration is visible in the series itself. It shows how a creator whose content falls outside platform policy relocates to services with looser moderation regimes. Those services carry their own audiences, monetization rules and content risks, and the creator's reach depends on them.

The series portrays Hughes as living in what it frames as a nightmare, in which many of his disciples died under “mysterious circumstances.” That phrase is the series' framing, and the documentary's structure presents the deaths as the emotional core of the story. Viewers will need to weigh how the deaths relate to the products, the injections and the lifestyle the series depicts. That link is what the three episodes are built to examine.

In my view, the format raises a question that extends beyond one creator. Looksmaxxing and biohacking communities are organized around self-experimentation, and their most visible members sell both the experiment and the substances used in it. A documentary that records the consumer side of that economy, the disciples as well as the seller, gives the audience a different picture than a profile of the influencer alone.

The broader context here is an ecosystem in which regulators, platforms and creators each respond to the others. The series documents one case of that cycle playing out.

The more useful reading of the series is as a clearer record of the creator economy's margins. Investigative documentaries of this kind can show how a product pipeline, a distribution strategy and a community of followers fit together, and they can do so without relying on abstraction. For a technology audience used to measuring platforms by engagement, the series is a reminder that the same mechanics operate in less regulated corners of online media, and that the harms there are measured in people rather than metrics.